Eli Lilly's tirzepatide products come up more than $1B short of expectations in Q3
Eli Lilly's tirzepatide products come up more than $1B short of expectations in Q3
kdunleavy
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *